奥 乐妥珠 单抗
单克 | |
---|---|
种类 | ? |
CD37 | |
ATC碼 |
|
识别 | |
CAS | 1372645-37-8 |
ChemSpider |
|
UNII | |
C4660H7136N1246O1452S30 | |
104,809.42 g·mol−1 |
该药
参考 资料[编辑]
- ^ Payandeh Z, Noori E, Khalesi B, Mard-Soltani M, Abdolalizadeh J, Khalili S. Anti-CD37 targeted immunotherapy of B-Cell malignancies. Biotechnology Letters. December 2018, 40 (11–12): 1459–1466. PMID 30293139. S2CID 52925605. doi:10.1007/s10529-018-2612-6.
- ^ Otlertuzumab (PDF). Statement On A Nonproprietary Name Adopted By The USAN Council. American Medical Association.
- ^ Otlertuzumab. ClinicalTrails.gov. U.S. National Library of Medicine.
|